The protective effect of erinacine A-enriched Hericium erinaceus mycelium ethanol extract on oxidative Stress-Induced neurotoxicity in cell and Drosophila models of spinocerebellar ataxia type 3.

[1]  G. Ciofani,et al.  Natural Antioxidant Compounds as Potential Pharmaceutical Tools against Neurodegenerative Diseases , 2022, ACS omega.

[2]  Pooja Mittal,et al.  Fungal Mushrooms: A Natural Compound With Therapeutic Applications , 2022, Frontiers in Pharmacology.

[3]  Guan Wang,et al.  Deconvoluting the Complexity of Reactive Oxygen Species (ROS) in Neurodegenerative Diseases , 2022, Frontiers in Neuroanatomy.

[4]  Manho Kim,et al.  Therapeutic potential of ginsenoside Rg3 and Rf for Huntington’s disease , 2021, In Vitro Cellular & Developmental Biology - Animal.

[5]  V. Pérez,et al.  Aggresome-Like Formation Promotes Resistance to Proteotoxicity in Cells from Long-Lived Species. , 2020, The journals of gerontology. Series A, Biological sciences and medical sciences.

[6]  T. G. Singh,et al.  Role of Nuclear Factor Kappa B (NF-KB) Signalling in Neurodegenerative Diseases: An Mechanistic Approach , 2020, Current neuropharmacology.

[7]  P. Maciel,et al.  From Pathogenesis to Novel Therapeutics for Spinocerebellar Ataxia Type 3: Evading Potholes on the Way to Translation , 2019, Neurotherapeutics.

[8]  M. Saraiva-Pereira,et al.  Genetic risk factors for modulation of age at onset in Machado-Joseph disease/spinocerebellar ataxia type 3: a systematic review and meta-analysis , 2018, Journal of Neurology, Neurosurgery, and Psychiatry.

[9]  M. Cvetanovic,et al.  Inhibition of NF-κB signaling in IKKβF/F;LysM Cre mice causes motor deficits but does not alter pathogenesis of Spinocerebellar ataxia type 1 , 2018, PloS one.

[10]  Yen-Po Chen,et al.  Neurohealth Properties of Hericium erinaceus Mycelia Enriched with Erinacines , 2018, Behavioural neurology.

[11]  Wei-Yong Lin,et al.  Caffeic acid and resveratrol ameliorate cellular damage in cell and Drosophila models of spinocerebellar ataxia type 3 through upregulation of Nrf2 pathway , 2018, Free radical biology & medicine.

[12]  M. França,et al.  Clinical Features of Machado-Joseph Disease. , 2018, Advances in experimental medicine and biology.

[13]  D. Souza,et al.  Peripheral Oxidative Stress Biomarkers in Spinocerebellar Ataxia Type 3/Machado–Joseph Disease , 2017, Front. Neurol..

[14]  Wei-Yong Lin,et al.  Treatment with Caffeic Acid and Resveratrol Alleviates Oxidative Stress Induced Neurotoxicity in Cell and Drosophila Models of Spinocerebellar Ataxia Type3 , 2017, Scientific Reports.

[15]  A. Szybińska,et al.  P53 Dysfunction in Neurodegenerative Diseases - The Cause or Effect of Pathological Changes? , 2017, Aging and disease.

[16]  Haw‐Wen Chen,et al.  Borage oil supplementation decreases lipopolysaccharide-induced inflammation and skeletal muscle wasting in mice , 2016 .

[17]  M. Friedman.  Chemistry, Nutrition, and Health-Promoting Properties of Hericium erinaceus (Lion's Mane) Mushroom Fruiting Bodies and Mycelia and Their Bioactive Compounds. , 2015, Journal of agricultural and food chemistry.

[18]  Yueh-Ting Tsai,et al.  Genotoxicity profile of erinacine A-enriched Hericium erinaceus mycelium , 2014, Toxicology reports.

[19]  Yueh-Ting Tsai,et al.  Evaluation of the toxicological safety of erinacine A-enriched Hericium erinaceus in a 28-day oral feeding study in Sprague-Dawley rats. , 2014, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[20]  S. Pulst,et al.  Modulation of the age at onset in spinocerebellar ataxia by CAG tracts in various genes. , 2014, Brain : a journal of neurology.

[21]  L. Borza.  A review on the cause-effect relationship between oxidative stress and toxic proteins in the pathogenesis of neurodegenerative diseases. , 2014, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi.

[22]  Ü. Langel,et al.  Inhibition of Autophagy via p53-Mediated Disruption of ULK1 in a SCA7 Polyglutamine Disease Model , 2013, Journal of Molecular Neuroscience.

[23]  N. Bhattacharyya,et al.  Regulation of miR-146a by RelA/NFkB and p53 in STHdhQ111/HdhQ111 Cells, a Cell Model of Huntington's Disease , 2011, PloS one.

[24]  T. Klockgether,et al.  FOXO4-dependent upregulation of superoxide dismutase-2 in response to oxidative stress is impaired in spinocerebellar ataxia type 3. , 2011, Human molecular genetics.

[25]  Ju-Yu Chen,et al.  p53 activation mediates polyglutamine-expanded ataxin-3 upregulation of Bax expression in cerebellar and pontine nuclei neurons , 2011, Neurochemistry International.

[26]  T. Yeh,et al.  Polyglutamine-expanded ataxin-7 upregulates Bax expression by activating p53 in cerebellar and inferior olivary neurons , 2010, Experimental Neurology.

[27]  I. Dimauro,et al.  AlphaB-crystallin is involved in oxidative stress protection determined by VEGF in skeletal myoblasts. , 2010, Free radical biology & medicine.

[28]  Martin J. Scanlon,et al.  Small heat-shock proteins interact with a flanking domain to suppress polyglutamine aggregation , 2010, Proceedings of the National Academy of Sciences.

[29]  N. Takei,et al.  Downregulation of NF-κB signaling by mutant huntingtin proteins induces oxidative stress and cell death , 2010, Cellular and Molecular Life Sciences.

[30]  C. Kuo,et al.  Decreased antioxidant enzyme activity and increased mitochondrial DNA damage in cellular models of Machado‐Joseph disease , 2009, Journal of neuroscience research.

[31]  N. Nukina,et al.  Decreased protein synthesis of Hsp27 associated with cellular toxicity in a cell model of Machado–Joseph disease , 2009, Neuroscience Letters.

[32]  T. Yeh,et al.  Polyglutamine-expanded ataxin-7 decreases nuclear translocation of NF-kappaB p65 and impairs NF-kappaB activity by inhibiting proteasome activity of cerebellar neurons. , 2007, Cellular signalling.

[33]  N. Nukina,et al.  Expression of Expanded Polyglutamine Proteins Suppresses the Activation of Transcription Factor NFκB* , 2006, Journal of Biological Chemistry.

[34]  S. Snyder,et al.  p53 Mediates Cellular Dysfunction and Behavioral Abnormalities in Huntington’s Disease , 2005, Neuron.

[35]  H. Kawagishi,et al.  Erinacine A increases catecholamine and nerve growth factor content in the central nervous system of rats , 2005 .

[36]  Horng‐Jyh Tsai,et al.  Full-length expanded ataxin-3 enhances mitochondrial-mediated cell death and decreases Bcl-2 expression in human neuroblastoma cells. , 2004, Biochemical and biophysical research communications.

[37]  D. Rubinsztein,et al.  Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin. , 2002, Human molecular genetics.